The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype-Reference-Cited by-同舟云学术

The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype

Published:2017-06-12 Issue:9 Volume:60 Page:1801-1812
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Vinué Ángela,Navarro Jorge,Herrero-Cervera Andrea,García-Cubas Marta,Andrés-Blasco Irene,Martínez-Hervás Sergio,Real José T.,Ascaso Juan F.,González-Navarro Herminia

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/article/10.1007/s00125-017-4330-3/fulltext.html

Reference40 articles.

1. Bornfeldt KE (2015) Uncomplicating the macrovascular complications of diabetes: the 2014 Edwin Bierman award lecture. Diabetes 64:2689–2697

2. Libby P, Pasterkamp G (2016) Requiem for the ʻvulnerable plaque. Eur Heart J 36:2984–2987

3. Baumgartl J, Baudler S, Scherner M et al (2006) Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis. Cell Metab 3:247–256

4. Gonzalez-Navarro H, Vila-Caballer M, Pastor MF et al (2007) Plasma insulin levels predict the development of atherosclerosis when IRS2 deficiency is combined with severe hypercholesterolemia in apolipoprotein E-null mice. Front Biosci 12:2291–2298

5. Han S, Liang CP, DeVries-Seimon T et al (2006) Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. Cell Metab 3:257–266

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with 1.25% cholesterol enriched diet produces severe fatty liver disease characterized by advanced fibrosis and inflammation and impaired autophagy in mice;The Journal of Nutritional Biochemistry;2024-12

2. Pharmacological therapy targeting the immune response in atherosclerosis;International Immunopharmacology;2024-11

3. Impact of hyperglycemia on immune cell function: a comprehensive review;Diabetology International;2024-08-12

4. Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs;Journal of Clinical Medicine;2024-08-09

5. GLP-1R agonist therapy and vaccine response: Neglected implications;Cytokine & Growth Factor Reviews;2024-08